Skip to main content

Peer Review reports

From: Therapeutic drug monitoring of six contraindicated/co-administered drugs by simple and green RP-HPLC-PDA; application to spiked human plasma

Original Submission
23 Aug 2023 Submitted Original manuscript
8 Sep 2023 Author responded Author comments - Maha A. Hegazy
23 Sep 2023 Author responded Author comments - Maha A. Hegazy
Resubmission - Version 2
8 Sep 2023 Submitted Manuscript version 2
10 Nov 2023 Reviewed Reviewer Report
6 Jan 2024 Reviewed Reviewer Report
15 Jan 2024 Author responded Author comments - Maha A. Hegazy
Resubmission - Version 3
15 Jan 2024 Submitted Manuscript version 3
20 Jan 2024 Author responded Author comments - Maha A. Hegazy
Resubmission - Version 4
20 Jan 2024 Submitted Manuscript version 4
23 Jan 2024 Reviewed Reviewer Report
23 Jan 2024 Reviewed Reviewer Report
23 Feb 2024 Author responded Author comments - Maha A. Hegazy
Resubmission - Version 5
23 Feb 2024 Submitted Manuscript version 5
26 Feb 2024 Author responded Author comments - Maha A. Hegazy
Resubmission - Version 6
26 Feb 2024 Submitted Manuscript version 6
2 Mar 2024 Reviewed Reviewer Report
5 Mar 2024 Reviewed Reviewer Report
Resubmission - Version 7
Submitted Manuscript version 7
Publishing
8 Mar 2024 Editorially accepted
5 Apr 2024 Article published 10.1186/s13065-024-01161-y

You can find further information about peer review here.

Back to article page